Racecadotril


Generic Medicine Info
Administration
Granules/ powder for oral susp: May be taken with or without food. May be added to food or dispersed in a glass of water or in the feeding bottle. Mix well & take immediately after prep. Powder may be administered directly into mouth.
Cap: May be taken with or without food. Swallow whole, do not open/break/chew. Administer initial cap at any time of the day. Subsequent cap, preferably taken prior to meals.
Contraindications
Diarrhoea associated with fever and/or bloody or purulent stools; antibiotic-associated diarrhoea. Patients who have experienced angioedema with ACE inhibitors.
Special Precautions
Patient with history of angioedema of any other aetiology. Administer racecadotril in combination with rehydration therapy. Avoid use in case of prolonged vomiting. Concomitant use with ACE inhibitors. Renal and hepatic impairment; avoid use in children with hepatic or renal impairment. Infants and children.
Adverse Reactions
Significant: Hypersensitivity or angioedema. Nervous system disorders: Headache. Respiratory, thoracic and mediastinal disorders: Tonsillitis (particularly in infants or children). Skin and subcutaneous tissue disorders: Rash, erythema nodosum, erythema multiforme, urticaria, papular rash, prurigo, pruritus.
Potentially Fatal: Rarely, severe skin reactions.
Drug Interactions
May increase the risk of angioedema with ACE inhibitors (e.g. captopril, enalapril).
CIMS Class
Antidiarrheals
ATC Classification
A07XA04 - racecadotril ; Belongs to the class of other antidiarrheals.
Disclaimer: This information is independently developed by CIMS based on racecadotril from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2024 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in